# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-23-007692
Filing Date
2023-06-21
Accepted
2023-06-21 16:22:02
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ADDITIONAL DEFINITIVE MATERIAL | alkermes-defa14a_062123.htm | DEFA14A | 11221
2 | GRAPHIC | alk-defa14a_img001.jpg | GRAPHIC | 9112758
3 | GRAPHIC | alk-defa14a_img002.jpg | GRAPHIC | 1078329
4 | GRAPHIC | alk-defa14a_img003.jpg | GRAPHIC | 3509504
5 | GRAPHIC | alk-defa14a_img004.jpg | GRAPHIC | 1051899
| Complete submission text file | 0001387131-23-007692.txt |  | 20316793

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35299 | Film No.: 231030154
SIC: 2834 Pharmaceutical Preparations